Glaukos (STU:6GJ) Marketable Securities : €211.9 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Glaukos Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Glaukos's Marketable Securities for the quarter that ended in Mar. 2024 was €211.9 Mil.

Glaukos's annual Marketable Securities declined from Dec. 2021 (€277.3 Mil) to Dec. 2022 (€220.1 Mil) and declined from Dec. 2022 (€220.1 Mil) to Dec. 2023 (€185.2 Mil).

Glaukos Marketable Securities Historical Data

The historical data trend for Glaukos's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos Marketable Securities Chart

Glaukos Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

100.40

252.99

277.31

220.11

185.20

Glaukos Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															225.44	192.90	179.84	185.20	211.94

Glaukos Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Glaukos (STU:6GJ) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Glaukos Marketable Securities Related Terms

Thank you for viewing the detailed overview of Glaukos's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Glaukos (STU:6GJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (STU:6GJ) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

GKOS:USA

Address

One Glaukos Way, Aliso Viejo, CA, USA, 92656

Website

https://www.glaukos.com

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Glaukos (STU:6GJ) Headlines

No Headlines